Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
IPI-504 | 857402-63-2 | sc-364512 sc-364512A | 10 mg 50 mg | $640.00 $1600.00 | ||
IPI-504 is an inhibitor of HSP90 family chaperones, including GRP94, leading to proteasomal degradation of client proteins and potential anti-cancer effects. | ||||||
Ganetespib | 888216-25-9 | sc-364496 sc-364496A | 10 mg 250 mg | $268.00 $1020.00 | ||
Ganetespib is an HSP90 inhibitor that might impact GRP94 function, leading to degradation of client proteins and potential anti-cancer effects. | ||||||
NVP-AUY922 | 747412-49-3 | sc-364551 sc-364551A sc-364551B sc-364551C sc-364551D sc-364551E | 5 mg 25 mg 100 mg 250 mg 1 g 5 g | $150.00 $263.00 $726.00 $1400.00 $2900.00 $11000.00 | 3 | |
NVP-AUY922 is an HSP90 inhibitor that might affect GRP94 function, leading to client protein degradation and potential anti-cancer activity. | ||||||
AT13387 | 912999-49-6 | sc-364415 sc-364415A | 10 mg 50 mg | $555.00 $1606.00 | ||
AT13387 is an HSP90 inhibitor that might affect GRP94 function, leading to degradation of client proteins and potential anti-cancer activity. | ||||||
PF-04929113 | 908115-27-5 | sc-364576 sc-364576A | 5 mg 50 mg | $495.00 $1980.00 | ||
PF-04929113 is an HSP90 inhibitor that might impact GRP94 function, leading to degradation of client proteins and potential anti-cancer effects. | ||||||
BIIB 021 | 848695-25-0 | sc-364434 sc-364434A | 5 mg 25 mg | $128.00 $650.00 | ||
BIIB 021 is a small molecule that targets HSP90 family chaperones, including GRP94, leading to client protein degradation and potential anti-cancer activity. |